Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.
Response to letter to the editors.
Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.
Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.
Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list.
Conundrum of treatment for early-stage hepatocellular carcinoma: radiofrequency ablation instead of liver transplantation as the first-line treatment?
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
